Reviews of surveys

Reviews of surveys over economische evaluaties

Ranking Preventive Interventions from Different Policy Domains: What Are the Most Cost-Effective Ways to Improve Public Health? (Van der Vliet et al., 2020 (externe link))

Census of economic evaluations in primary prevention 2014-2019: a scoping review protocol (Jackson & Shiell, 2020 (externe link))

Developing a Web-Based Cost Assessment Tool for Colorectal Cancer Screening Programs (Hoover et al., 2020 (externe link))

Alcohol consumption's attributable disease burden and cost-effectiveness of targeted public health interventions: a systematic review of mathematical models (Bardach et al., 2019 (externe link))

The role of information provision in economic evaluations of non-invasive prenatal testing: a systematic review (John et al., 2019 (externe link))

What do cost-effective health behaviour-change interventions contain? A comparison of six domains (Beard et al., 2019 (externe link))

Dynamic transmission models and economic evaluations of pneumococcal conjugate vaccines: a quality appraisal and limitations (Løchen & Anderson, 2019 (externe link))

Economic evaluations of public health implementation-interventions: a systematic review and guideline for practice (Reeves et al., 2019 (externe link))

The cost-effectiveness of public health interventions examined by the National Institute for Health and Care Excellence from 2005 to 2018 (Owen & Fischer, 2019 (externe link))

A Systematic Review of Methods, Study Quality, and Results of Economic Evaluation for Childhood and Adolescent Obesity Intervention (Zanganeh et al., 2019 (externe link))

Present challenges in cervical cancer prevention: Answers from cost-effectiveness analyses (Diaz et al., 2018 (externe link))

Systematic reviews of economic evaluations in Health Technology Assessment: a review of characteristics and applied methods (Luhnen et al., 2018 (externe link))

Economic evaluations of eHealth technologies: A systematic review (Sanyal et al., 2018 (externe link))

The cost-effectiveness of public health interventions examined by NICE from 2011 to 2016 (Owen et al., 2017 (externe link))

Distribution-Weighted Cost-Effectiveness Analysis Using Lifetime Health Loss (Hernaes et al., 2017 (externe link))

Systematic Review of Health Economic Impact Evaluations of Risk Prediction Models: Stop Developing, Start Evaluating (van Giessen et al., 2017 (externe link))

Evidence synthesis to inform model-based cost-effectiveness evaluations of diagnostic tests: a methodological review of health technology assessments (Shinkins et al., 2017 (externe link))

Economic evaluations of health technologies in Dutch healthcare decision-making: a qualitative study of the current and potential use, barriers, and facilitators (Roseboom et al., 2017 (externe link))

A literature-based economic evaluation of healthcare preventable adverse events in Europe (Agbabiaka et al., 2016 (externe link))

Cost-effectiveness and sustainability of breast cancer screening and new anticancer drugs (Mustacchi & Generali, 2017 (externe link))

How to prepare a systematic review of economic evaluations for informing evidence-based healthcare decisions: a five-step approach (part 1/3) (Van Mastrigt et al., 2016 (externe link))

How to prepare a systematic review of economic evaluations for clinical practice guidelines: database selection and search strategy development (part 2/3) (Thielen et al., 2016 (externe link))

How to prepare a systematic review of economic evaluations for informing evidence-based healthcare decisions: data extraction, risk of bias, and transferability (Part 3/3) (Wijnen et al., 2016 (externe link))

A Systematic Review of Health Economic Evaluation Studies Using the Patient's Perspective (Bilvick Tai et al., 2016 (externe link))

Lack of Cost-Effectiveness Analyses to Address Healthy People 2020 Priority Areas (Neumann et al., 2016 (externe link))

Extended Cost-Effectiveness Analysis for Health Policy Assessment: A Tutorial (Verguet et al., 2016 (externe link))

Economic Evaluation in Global Perspective: A Bibliometric Analysis of the Recent Literature (Pitt et al., 2016 (externe link))

Systematic overview of cost-effectiveness thresholds in ten countries across four continents (Schwarzer et al., 2015 (externe link))

Systematic review of economic evaluations of vaccination programs in mainland China: Are they sufficient to inform decision making? (Pan et al., 2015 (externe link))

A Systematic Review of Health Economic Evaluations of Diagnostic Biomarkers (Oosterhoff et al., 2015 (externe link))

Conducting systematic reviews of economic evaluations (Gomersall et al., 2015 (externe link))

The changing face of the cost-utility literature, 1990-2012 (Neumann et al., 2015 (externe link))

A decade of investment in infection prevention: A cost-effectiveness analysis  (Dick et al., 2015 (externe link))

Estimating QALY Gaines in Applied Studies: A Review of Cost-Utility Analyses Published in 2010 (Wisloff et al., 2014 (externe link))

Generalizability of cost-utility analyses across countries and settings  (Ginsberg, 2013 (externe link))

The role of health economic analyses in vaccine decision making  (Black, 2013 (externe link))

Research Priorities for Economic Analyses of Prevention: Current Issues and Future Directions  (Crowley et al., 2013 (externe link))

Systematic review of incremental non-vaccine cost estimates used in cost-effectiveness analysis on the introduction of rotavirus and pneumococcal vaccines (De la Hoz-Restrepo et al., 2013 (externe link))

Systematic review of economic evaluation analyses of available vaccines in Spain from 1990 to 2012 (Cortes et al., 2013 (externe link))

Timely and complete publication of economic evaluations alongside randomized controlled trials  (Thorn et al., 2013 (externe link))

Public health and prevention in Europe: is it cost-effective? (Simoens, 2011 (externe link))

Coauthorship and institutional collaborations on cost-effectiveness analyses: a systematic network analysis  (Catala-Lopez et al., 2012 (externe link))

Making the economic case for prevention - a view from Wales  (Hale et al., 2012 (externe link))

Intervention strategies to reduce the burden of non-communicable diseases in Mexico: cost effectiveness analysis (Salomon et al., 2012 (externe link))

Cost-Effectiveness of Antiretroviral Therapy for Prevention (Kahn et al., 2011 (externe link))

Cost-effectiveness research on preventive interventions: a survey of the publications in 2008 (van Gils et al., 2010 (externe link)).

Burden of disease and economic evaluation of healthcare interventions: are we investigating what really matters? (Catala-Lopez et al., 2011 (externe link))

Does prevention really pay? (Daly, 2011 (externe link))

Are economic evaluations an important tool in vaccine policy decisions? (Jacobs, 2011 (externe link))

Methodologie

Methodologie van economische evaluaties

Cost-per-diagnosis as a metric for monitoring cost-effectiveness of HIV testing programmes in low-income settings in southern Africa: health economic and modelling analysis (Phillips et al., 2019 (externe link))

Fetal Down syndrome screening models for developing countries; Part II: Cost-benefit analysis (Wanapirak et al., 2019 (externe link))

The estimation of economic effectiveness of preventive measures of non-infectious diseases (Palamar & Gruzeva, 2020 (externe link))

Mapping the evidence on health equity considerations in economic evaluations of health interventions: a scoping review protocol (Besar Sa'aid et al., 2020 (externe link))

Understanding cost data collection tools to improve economic evaluations of health interventions (Chapel & Wang, 2019 (externe link))

Health economic evaluation of diabetes prevention and management strategies (Laxy & Kähm, 2019 (externe link))

Economic Evaluation of Public Health Interventions: An Application to Interventions for the Prevention of Violence Against Women and Girls Implemented by the "What Works to Prevent Violence Against Women and Girls?" Global Program (Ferrari et al., 2019 (externe link))

An overview of systematic reviews of economic evaluations of pharmacy-based public health interventions: addressing methodological challenges (Costa et al., 2019 (externe link))

Systematic reviews as a “lens of evidence”: Determinants of cost-effectiveness of breast cancer screening (Mandrik et al., 2019 (externe link))

Economics of public health programs for underserved populations: a review ofeconomic analysis of the National Breast and Cervical Cancer Early Detection Program (Khusalani et al., 2019 (externe link))

The Structure and Parameterization of the Breast Cancer Transition Model Among Chinese Women (Huang et al., 2019 (externe link))

PRIMEtime CE: a multistate life table model for estimating the cost-effectiveness of interventions affecting diet and physical activity (Briggs et al., 2019 (externe link))

Making Hard Choices in Local Public Health Spending With a Cost-Benefit Analysis Approach (Robertson et al., 2019 (externe link))

The Diabetes Prevention Impact Tool Kit: An Online Tool Kit to Assess the Cost-Effectiveness of Preventing Type 2 Diabetes (Lanza et al., 2019 (externe link))

Cost-effectiveness of physical activity interventions in adolescents: model development and illustration using two exemplar interventions (Gc et al., 2019 (externe link))

PRIMEtime CE: a multistate life table model for estimating the cost-effectiveness of interventions affecting diet and physical activity (Briggs et al., 2019 (externe link))

Towards the automated economic assessment of newborn screening for rare diseases (Prieto-González et al., 2019 (externe link))

Systematic review of the methods used in economic evaluations of targeted physical activity and sedentary behaviour interventions (Cochrane et al., 2019 (externe link))

A systematic review of decision analytic modeling techniques for the economic evaluation of dental caries interventions (Qu et al., 2019 (externe link))

Cost-effectiveness of public health interventions against human influenza pandemics in France: a methodological contribution from the FLURESP European Commission project (Beresniak et al., 2019 (externe link))

Cost Effectiveness of Elderly Pneumococcal Vaccination in Presence of Higher-Valent Pneumococcal Conjugate Childhood Vaccination: Systematic Literature Review with Focus on Methods and Assumptions (Treskova et al., 2019 (externe link))

Appraising the cost-effectiveness of vaccines in the UK: Insights from the Department of Health Consultation on the revision of methods guidelines (O'Mahony & Paulden (externe link))

The Diabetes Prevention Impact Tool Kit: An Online Tool Kit to Assess the Cost-Effectiveness of Preventing Type 2 Diabetes (Lanza et al., 2019 (externe link))

Toward economic evaluation of the value of vaccines and other health technologies in addressing AMR (Sevilla et al., 2018 (externe link))

Economic evaluations in community aged care: a systematic review (Bulamu et al., 2018 (externe link))

Methodological Challenges in the Economic Evaluation of Occupational Health and Safety Programmes (Steel et al., 2018 (externe link))

Model Comparisons of the Effectiveness and Cost-Effectiveness of Vaccination: A Systematic Review of the Literature (Drolet et al., 2018 (externe link))

Future Directions for Cost-effectiveness Analyses in Health and Medicine (Neumann et al., 2018 (externe link))

Event simulation and external validation applied in published health economic models for obesity: a systematic review (Schwander et al., 2018 (externe link))

A dynamic Bayesian Markov model for health economic evaluations of interventions in infectious disease (Haeussler et al., 2018 (externe link))

Cost-benefit analysis of vaccination: a comparative analysis of eight approaches for valuing changes to mortality and morbidity risks (Park et al., 2018 (externe link))

Simple but not simpler: a systematic review of Markov models for economic evaluation of cervical cancer screening (Viscondi et al., 2018 (externe link))

The efficiency-frontier approach for health economic evaluation versus cost-effectiveness thresholds and internal reference pricing: combining the best of both worlds? (Sandmann et al., 2018 (externe link))

Critical Analysis of Markov Models Used for the Economic Evaluation of Colorectal Cancer Screening: A Systematic Review (Silva-Illanes & Espinoza, 2018 (externe link))

Assessing the value of screening tools: reviewing the challenges and opportunities of cost-effectiveness analysis (Iraqorri & Spackman, 2018 (externe link))

Systematic assessment of decision analytic models for the cost-effectiveness of bariatric surgery for morbid obesity (Alsumali et al., 2018 (externe link))

A qualitative investigation of the health economic impacts of bariatric surgery for obesity and implications for improved practice in health economics (Campbell et al., 2018 (externe link))

The Impact of Hospital Costing Methods on Cost-Effectiveness Analysis: A Case Study (Leal et al., 2018 (externe link))

Reconciling ethical and economic conceptions of value in health policy using the capabilities approach: A qualitative investigation of Non-Invasive Prenatal Testing (Kibel & Vanstone, 2017 (externe link))

A method for the inclusion of physical activity-related health benefits in cost-benefit analysis of built environment initiatives (Zapata-Diomedi et al., 2017 (externe link))

Inclusion of the value of herd immunity in economic evaluations of vaccines. A systematic review of methods used (Nymark et al., 2017 (externe link))

Can Economic Model Transparency Improve Provider Interpretation of Cost-effectiveness Analysis? Evaluating Tradeoffs Presented by the Second Panel on Cost-effectiveness in Health and Medicine (Padula et al., 2017 (externe link))

WHO guide on the economic evaluation of influenza vaccination (Newall et al.,. 2017 (externe link))

A Review of Generic Preference-Based Measures for Use in Cost-Effectiveness Models (Brazier et al., 2017 (externe link))

Challenges and recommendations for the health-economic evaluation of primary prevention programmes for dementia (Handels & Wimo, 2017 (externe link))

Capturing Budget Impact Considerations Within Economic Evaluations: A Systematic Review of Economic Evaluations of Rotavirus Vaccine in Low- and Middle-Income Countries and a Proposed Assessment Framework (Carvalho et al., 2017 (externe link))

When cost-effective interventions are unaffordable: Integrating cost-effectiveness and budget impact in priority setting for global health programs (Bilinski et al., 2017 (externe link))

The search for relevant outcome measures for cost-utility analysis of systemic family interventions in adolescents with substance use disorder and delinquent behavior: a systematic literature review (Schawo et al., 2017 (externe link))

Predicting carer health effects for use in economic evaluation (Al-Janabi et al., 2017 (externe link))

Inclusion of equity in economic analyses of public health policies: systematic review and future directions (Lal et al., 2017 (externe link))

Dynamic transmission models for economic analysis applied to health care-associated infections: A review of the literature (Nelson et al., 2017 (externe link))

How to design the cost-effectiveness appraisal process of new healthcare technologies to maximise population health: A conceptual framework (Johanessen et al., 2017 (externe link))

Development and application of an economic model (EQUIPTMOD) to assess the impact of smoking cessation (Coyle et al., 2017 (externe link))

A systematic literature review of methods of incorporating mortality in cost-effectiveness analyses of lipid-lowering therapies (Ortendahl et al., 2017 (externe link))

Modelling and optimal control of pneumonia disease with cost-effective strategies (Tilahun et al., 2017 (externe link))

Development of a web-based application and multicountry analysis framework for assessing interdicted infections and cost-utility of screening donated blood for HIV, HCV and HBV (Custer et al., 2017 (externe link))

Policies for Use of Real-World Data in Health Technology Assessment (HTA): A Comparative Study of Six HTA Agencies (Makady et al., 2017 (externe link))

The influence of time horizon on results of cost-effectiveness analyses (Kim et al., 2017 (externe link))

Accounting for Cured Patients in Cost-Effectiveness Analysis (Othus et al., 2017 (externe link))

Economics in "Global Health 2035": a sensitivity analysis of the value of a life year estimates (Chang et al., 2017 (externe link))

Why Early Prevention of Childhood Obesity Is More Than a Medical Concern: A Health Economic Approach (Sonntag, 2017 (externe link))

Using Cost-Effectiveness Analysis to Address Health Equity Concerns (Cookson et al., 2017 (externe link))

Mix and match. A simulation study on the impact of mixed-treatment comparison methods on health-economic outcomes (Vemer et al., 2017 (externe link))

The insights of health and welfare professionals on hurdles that impede economic evaluations of welfare interventions (Schepers et al., 2017 (externe link))

Beyond cost-effectiveness: Using systems analysis for infectious disease preparedness (Phelps et al., 2017 (externe link))

Risk of bias in model-based economic evaluations: the ECOBIAS checklist (Adarkwah et al., 2016 (externe link))

Valuing Meta-Health Effects for Use in Economic Evaluations to Inform Reimbursement Decisions: A Review of the Evidence (De Abreu Lourenco et al., 2016) (externe link)

Maximizing Health or Sufficient Capability in Economic Evaluation? A Methodological Experiment of Treatment for Drug Addiction (Goranitis et al., 2016 (externe link))

Emergent Challenges in Determining Costs for Economic Evaluations (Jacobs & Barnett, 2016 (externe link))

Economic Evaluation of Obesity Prevention in Early Childhood: Methods, Limitations and Recommendations (Döring et al., 2016 (externe link))

Economic evaluation of integrated new technologies for health and social care: Suggestions for policy makers, users and evaluators (Wildman et al., 2016 (externe link))

Challenges in Cost-Effectiveness Analysis Modelling of HPV Vaccines in Low- and Middle-Income Countries: A Systematic Review and Practice Recommendations (Ekwunife et al., 2016 (externe link))

A Systematic Review of Economic Evaluation Methodologies Between Resource-Limited and Resource-Rich Countries: A Case of Rotavirus Vaccines (Thiboonboon et al., 2016 (externe link))

Systematic review and overview of health economic evaluation models in obesity prevention and therapy (Schwander et al., 2016 (externe link))

A Framework for Developing the Structure of Public Health Economic Models (Squires et al., 2016 (externe link))

Unremarked or Unperformed? Systematic Review on Reporting of Validation Efforts of Health Economic Decision Models in Seasonal Influenza and Early Breast Cancer (de Boer et al., 2016 (externe link))

Strengthening Cost-Effectiveness Analysis for Public Health Policy (Russell & Sinha, 2016 (externe link))

Cost Effectiveness of HPV Vaccination: A Systematic Review of Modelling Approaches (Pink et al., 2016 (externe link))

A systematic review of modelling approaches in economic evaluations of health interventions for drug and alcohol problems (Hoang et al., 2016 (externe link))

Economic Evaluation of Vaccination Programmes in Older Adults and the Elderly: Important Issues and Challenges (Dirmesropian et al., 2016 (externe link))

Economic Evaluation of Mental Health Interventions: A Guide to Costing Approaches (Shearer et al., 2016 (externe link))

Economic Evaluation of Childhood Obesity Interventions: Reflections and Suggestions (Frew, 2016 (externe link))

NETIMIS: Dynamic Simulation of Health Economics Outcomes Using Big Data (Johnson et al., 2016 (externe link))

Modeling and Cost-Effectiveness in HIV Prevention (Jacobsen & Walensky, 2016 (externe link))

Methodological Challenges to Economic Evaluations of Vaccines: Is a Common Approach Still Possible? (Jit & Hutubessy, 2016 (externe link))

A systematic literature review of the key challenges for developing the structure of public health economic models (Squires et al., 2016 (externe link))

Beware of Kinked Frontiers: A Systematic Review of the Choice of Comparator Strategies in Cost-Effectiveness Analyses of Human Papillomavirus Testing in Cervical Screening (O'Mahony et al., 2015 (externe link))

Quality assessment of economic evaluations of health promotion programs for children and adolescents-a systematic review using the example of physical activity (Korber, 2015 (externe link))

Methods Used in Economic Evaluations of Chronic Kidney Disease Testing - A Systematic Review (Sutton et al., 2015 (externe link))

Methods for Health Economic Evaluation of Vaccines and Immunization Decision Frameworks: A Consensus Framework from a European Vaccine Economics Community (Ultsch et al., 2016 (externe link))

How to Measure Costs and Benefits of eHealth Interventions: An Overview of Methods and Frameworks (Bergmo, 2015 (externe link))

A qualitative study on the views of experts regarding the incorporation of non-health outcomes into the economic evaluations of public health interventions (van Mastrigt et al., 2015 (externe link))

The Missing Stakeholder Group: Why Patients Should be Involved in Health Economic Modelling (van Voorn et al., 2015 (externe link))

Incorporating Psychological Predictors of Treatment Response into Health Economic Simulation Models: A Case Study in Type 1 Diabetes (Kruger et al., 2015 (externe link))

A Framework for Including Family Health Spillovers in Economic Evaluation (Al-Janabi et al., 2015 (externe link))

Cost-Effective Control of Infectious Disease Outbreaks Accounting for Societal Reaction (Fast et al., 2015 (externe link))

Understanding Cost-Effectiveness Analyses: An Explanation Using Three Different Analyses of Lung Cancer Screening (Curl et al., 2015 (externe link))

Exploring Outcomes to Consider in Economic Evaluations of Health Promotion Programs: What Broader Non-Health Outcomes Matter Most? (Benning et al., 2015 (externe link))

Discounting in the evaluation of the cost-effectiveness of a vaccination programme: A critical review (Jit & Mibei, 2015 (externe link))

Dealing with Time in Health Economic Evaluation: Methodological Issues and Recommendations for Practice (O'Mahony et al., 2015 (externe link))

Stakeholders' perception on including broader economic impact of vaccines in economic evaluations in low and middle income countries: a mixed methods study (van der Putten et al., 2015 (externe link))

Strengthening national decision-making on immunization by building capacity for economic evaluation: Implementing ProVac in Europe (Blau et al., 2015 (externe link))

Costing bias in economic evaluations (Frappier et al., 2015 (externe link))

Accounting for Heterogeneity in Relative Treatment Effects for Use in Cost-Effectiveness Models and Value-of-Information Analyses (Welton et al., 2015 (externe link))

DEALING WITH MISSING BEHAVIORAL ENDPOINTS IN HEALTH PROMOTION RESEARCH BY MODELING COGNITIVE PARAMETERS IN COST-EFFECTIVENESS ANALYSES OF BEHAVIORAL INTERVENTIONS: A VALIDATION STUDY (Prenger et al., 2014 (externe link))

Sustainability of Behavioral Interventions: Beyond Cost-Effectiveness Analysis (Brown et al., 2014 (externe link))

IDENTIFICATION AND REVIEW OF COST-EFFECTIVENESS MODEL PARAMETERS: A QUALITATIVE STUDY (Kaltenthaler et al., 2014 (externe link))

Guidance on priority setting in health care (GPS-Health): the inclusion of equity criteria not captured by cost-effectiveness analysis (Norheim et al., 2014 (externe link))

Estimating Productivity Costs in Health Economic Evaluations: A Review of Instruments and Psychometric Evidence (Tang, 2014 (externe link))

Development of a quality framework for models of cervical screening and its application to evaluations of the cost-effectiveness of HPV vaccination in developed countries (Simonella & Canfell, 2014 (externe link))

Mind the gaps: what's missing from current economic evaluations of universal HPV vaccination? (Marsh et al., 2014 (externe link))

Economics of chronic diseases protocol: cost-effectiveness modelling and the future burden of non-communicable disease in Europe (Divajeva et al., 2014 (externe link))

DISTRIBUTIONAL COST-EFFECTIVENESS ANALYSIS OF HEALTH CARE PROGRAMMES - A METHODOLOGICAL CASE STUDY OF THE UK BOWEL CANCER SCREENING PROGRAMME (Asaria et al., 2014 (externe link))

Avoiding research waste through cost-effectiveness analysis: the example of medication adherence-enhancing interventions (Gandjour, 2014 (externe link))

Key issues and challenges in estimating the impact and cost-effectiveness of quadrivalent influenza vaccination (Quinn et al., 2014 (externe link))

Challenges in Modelling the Cost Effectiveness of Various Interventions for Cardiovascular Disease (Burgers et al., 2014 (externe link))

Methodological issues for the economic evaluation of health interventions: A concise state of the art (Di Tanna & Baio, 2013 (externe link))

Inter-sectoral costs and benefits of mental health prevention: towards a new classification scheme (Drost et al., 2013 (externe link))

A pilot randomised trial to assess the methods and procedures for evaluating the clinical effectiveness and cost-effectiveness of Exercise Assited Reduction then Stop (EARS) among disadvantaged smoker (Taylor et al., 2014 (externe link)) 

Estimating QALY Gaines in Applied Studies: A Review of Cost-Utility Analyses Published in 2010 (Wisloff et al., 2014 (externe link))

Perspectives on econometric modelling to inform policy: a UK qualitative case study of minimum unit pricing of alcohol  (Katikireddi et al., 2013 (externe link))

How to include informal care in economic evaluations  (Hoefman et al., 2013 (externe link))

Economic evaluations of implemented vaccination programmes: key methodological challenges in retrospective analyses  (Newall et al., 2013 (externe link))

TRIVAC decision-support model for evaluating the cost-effectiveness of Haemophilus influenzae type b, pneumococcal and rotavirus vaccination (Clark et al., 2013 (externe link))

Smoking cessation treatment and outcomes patterns simulation: a new framework for evaluating the potential health and economic impact of smoking cessation interventions (Getsios et al., 2013 (externe link))

A multi-criteria decision analysis perspective on the health economic evaluation of medical interventions (Postmus et al., 2013 (externe link))

The use of cost-benefit analysis in road assessments: a methodological inquiry (Vecino-Ortiz & Hyder, 2013 (externe link)) 

Cost-effectiveness analyses of training: a manager's guide  (O. Malley G et al., 2013 (externe link))

Understanding the Cost-Effectiveness of Influenza Vaccination in Children: Methodological Choices and Seasonal Variability (Newall et al., 2013 (externe link))

A critical literature review of health economic evaluations of rotavirus vaccination  (Aballea et al., 2013 (externe link)) 

Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement (Husereau et al., 2013 (externe link))

Endogenous cost-effectiveness analysis and health care technology adoption  (Jena & Philipson, 2012 (externe link))

Cost-effectiveness models of pneumococcal conjugate vaccines: variability and impact of modeling assumptions  (Farkouh et al., 2012 (externe link))

Incorporating social network effects into cost-effectiveness analysis: a methodological contribution with application to obesity prevention (Konchak & Prasad, 2012 (externe link))

Specific guidelines for assessing and improving the methodological quality of economic evaluations of newborn screening (Langer et al., 2012 (externe link))

Multicohort Models in Cost-Effectiveness Analysis: Why Aggregating Estimates over Multiple Cohorts Can Hide Useful Information (O'Mahony et al., 2012 (externe link))

Applying economic evaluation to public health interventions: the case of interventions to promote physical activity (Trueman & Anokye, 2012 (externe link))

Estimating cost-effectiveness in public health: a summary of modelling and valuation methods (Marsh et al., 2012 (externe link))

Economic evaluation of vaccination: capturing the full benefits, with an application to human papillomavirus  (Bärnighausen et al., 2012 (externe link))

Applying the net-benefit framework for analyzing and presenting cost-effectiveness analysis of a maternal and newborn health intervention   (Hounton & Newlands, 2012b)

Methods for Estimating Subgroup Effects in Cost-Effectiveness Analyses That Use Observational Data   (Kreif et al., 2012)

Applying the net-benefit framework for assessing cost-effectiveness of interventions towards universal health coverage  (Hounton & Newlands, 2012 (externe link))

Decision analysis, economic evaluation, and newborn screening: challenges and opportunities (Prosser et al., 2012 (externe link))

Valuing the economic benefits of complex interventions: when maximising health is not sufficient (Payne et al., 2012 (externe link))

A critical literature review of health economic evaluations in pertussis booster vaccination (Millier et al., 2012 (externe link))

Moving beyond a limited follow-up in cost-effectiveness analyses of behavioral interventions (Prenger et al., 2012 (externe link))

Average cost-effectiveness ratio with censored data (Bang & Zhao, 2012 (externe link))

The CHD challenge: Comparing cost-effectiveness models  (Turner et al., 2011 (externe link))

The quality of three decision-analytic diabetes models: a systematic health economic assessment (Becker et al., 2011 (externe link))

Characteristics and quality of pediatric cost-utility analyses (Kromm et al., 2011 (externe link))

Application of Classic Utilities to Published Pediatric Cost-Utility Studies (Finnell et al., 2011 (externe link))

Methodological concerns with economic evaluations of meningococcal vaccines (Kauf, 2010 (externe link)).

Human papillomavirus vaccine introduction in low and middle income countries: guidance on the use of cost-effectiveness models (Jit et al., 2011 (externe link))

Cost effectiveness of pediatric pneumococcal conjugate vaccines: a comparative assessment of decision-making tools (Chaiyakunapruk et al., 2011 (externe link))

Cost-utility analysis: current methodological issues and future perspectives (Nuijten & Dubois, 2011 (externe link))

Conceptual Framework for Standard Economic Evaluation of Physical Activity Programs in Primary Prevention (Wolfenstetter, 2011 (externe link))

Using cost-effectiveness analysis to support research and development portfolio prioritization for product innovations in measles vaccination (Garrison, L. P. et al., 2011 (externe link))

Patient experience - the ingredient missing from cost-effectiveness calculations (Curtis, 2011 (externe link))

Power and sample size for cost-effectiveness analysis: fFN neonatal screening (Boyd et al., 2011 (externe link))

Surrogates, meta-analysis and cost-effectiveness modelling: a combined analytic approach (Hawkins et al., 2011 (externe link))

The cost-effectiveness of public health interventions (Owen et al., 2011 (externe link))

Cost-effectiveness of osteoporosis screening followed by treatment: the impact of medication adherence (Hiligsmann et al., 2010 (externe link))

Developing guidelines for good practice in the economic evaluation of occupational safety and health interventions (Tompa et al., 2010 (externe link)).

Conducting cost-effectiveness analyses of type 2 diabetes in low- and middle income countries: can locally generated observational study data overcome methodological limitations? (Baik et al., 2010 (externe link))

Estimation of life-years gained and cost effectiveness based on cause-specific mortality (Kim & Thompson, 2010 (externe link)).

Modelling lifetime QALYs and health care costs from different drinking patterns over time: a Markov model (Barbosa et al., 2010 (externe link))

Future costs in cost-effectiveness analysis: an empirical assessment (Kruse et al., 2010 (externe link)).

Economic evaluation and the postponement of health care costs (van Baal et al., 2010-1 (externe link))

Standardizing the Inclusion of Indirect Medical Costs in Economic Evaluations (van Baal et al., 2010-2 (externe link))

Onzekerheid in modelstudies

Onzekerheid in modelstudies

Dynamic transmission models and economic evaluations of pneumococcal conjugate vaccines: a quality appraisal and limitations (Lochen & Anderson, 2020 (externe link))

Review of vaccine effectiveness assumptions used in economic evaluations of infant pneumococcal conjugate vaccine (Wasserman et al., 2017 (externe link))

The impact of assumptions regarding vaccine-induced immunity on the public health and cost-effectiveness of hepatitis A vaccination: Is one dose sufficient? (Curran et al., 2016 (externe link))

Mind the Gap! A Multilevel Analysis of Factors Related to Variation in Published Cost-Effectiveness Estimates within and between Countries (Boehler & Lord, 2015 (externe link))

The economics of vaccination (Chen & Toxvaerd, 2014 (externe link))

Changes in costs and effects after the implementation of disease management programs in the Netherlands: variability and determinants (Tsiachristas et al., 2014 (externe link))

Does Age Modify the Cost-Effectiveness of Community-Based Physical Activity Interventions? (Roux et al., 2014) (externe link)

Do current cost-effectiveness analyses reflect the full value of childhood vaccination in Europe?: A rotavirus case study (Bruggenjurgen et al., 2014 (externe link))

The influence of waiting times on cost-effectiveness: a case study of colorectal cancer mass screening (Chauvin et al., 2013 (externe link))

Cost-effectiveness: euros per QALY is not enough (van den Berg et al., 2012 (externe link))

The impact of inclusion criteria in health economic assessments  (Richter et al., 2011 (externe link))

Exploring Model Uncertainty in Economic Evaluation of Health Interventions: The Example of Rotavirus Vaccination in Vietnam (Kim et al., 2010 (externe link))

Calibrating models in economic evaluation: a seven-step approach (Vanni et al., 2011 (externe link))

Cost-effectiveness of influenza vaccination of people aged 50-64 years in Australia: results are inconclusive (Mogasale & Barendregt, 2011 (externe link))

Industry involvement and baseline assumptions of cost-effectiveness analyses: diagnostic accuracy of the Papanicolaou test. (Polyzos et al., 2011 (externe link))

Cost effectiveness of pediatric pneumococcal conjugate vaccines: a comparative assessment of decision-making tools (Chaiyakunapruk et al., 2011 (externe link))

Results from evaluations of models and cost-effectiveness tools to support introduction decisions for new vaccines need critical appraisal (Hutubessy et al., 2011 (externe link))

Within a smoking-cessation program, what impact does genetic information on lung cancer need to have to demonstrate cost-effectiveness (Gordon et al., 2010 (externe link))

Uncertainty in decision-making: value of additional information in the cost-effectiveness of lifestyle intervention in overweight and obese people  (Galani et al., 2008 (externe link))

Uitkomstmaten

Uitkomstmaten in economische evaluaties

Valuing the health states associated with breast cancer screening programmes: A systematic review of economic measures (Bromley et al., 2019 (externe link))

A Systematic Review of Cost-Effectiveness Studies Reporting Cost-per-DALY Averted (Neumann et al., 2016 (externe link))

Measuring Care-Related Quality of Life of Caregivers for Use in Economic Evaluations: CarerQol Tariffs for Australia, Germany, Sweden, UK, and US (Hoefman et al., 2016 (externe link))

Determinants of Change in the Cost-Effectiveness Threshold (Paulden et al., 2016 (externe link))

Sources and Characteristics of Utility Weights for Economic Evaluation of Pediatric Vaccines: A Systematic Review (Herdman et al., 2016 (externe link))

A systematic review of instruments for measuring outcomes in economic evaluation within aged care (Bulamu et al., 2015 (externe link))

Using health state utility values in models exploring the cost-effectiveness of health technologies (Ara & Wailoo, 2012 (externe link))

Cost-effectiveness comparison of breast cancer screening and vascular event primary prevention with aspirin in Wales (Morgan, 2011 (externe link))

Using threshold values for cost per quality-adjusted life-year gained in healthcare decision (Cleemput et al., 2011 (externe link))

Outcome measurement in economic evaluations of public health interventions: a role for the capability approach? (Lorgelly et al., 2010 (externe link))

Methods for assessing the cost-effectiveness of public health interventions: key challenges and recommendations. (Weatherly et al., 2009 (externe link))

The Potential to Forgo Social Welfare Gains through Overrelianceon Cost Effectiveness/Cost Utility Analyses in the Evidence Base for Public Health. (Cohen & Patel, 2009 (externe link))

The role of costs in comparative effectiveness research. (Garber & Sox, 2010 (externe link))

Cost-utility estimates in depression: does the valuation method matter? (Jonkers et al., 2010 (externe link))

Does adjusting for health-related quality of life matter in economic evaluations of cancer-related interventions? (Greenberg & Neumann, 2011 (externe link))